Effects of RG7652, a Monoclonal Antibody Against PCSK9, on LDL-C, LDL-C Subfractions, and Inflammatory Biomarkers in Patients at High Risk of or With Established Coronary Heart Disease (from the Phase 2 EQUATOR Study)
Baruch, Amos, PhD, Mosesova, Sofia, PhD, Davis, John D., PhD, Budha, Nageshwar, PhD, Vilimovskij, Alexandr, MD, Kahn, Robert, MD, Peng, Kun, PhD, Cowan, Kyra J., PhD, Harris, Laura Pascasio, MPH, Gelzleichter, Thomas, PhD, Lehrer, Josh, MD, Davis, John C., MD, Tingley, Whittemore G., MD
Published in The American journal of cardiology (15.05.2017)
Published in The American journal of cardiology (15.05.2017)
Get full text
Journal Article